Sign In
CPSI Share                                                                      
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​
Publication Type: Medication Safety Notice
Single or Multiple Incident: Multiple
Date: 8/1/2020 12:00:00 AM
Country: Australia

This safety notice highlights the potential medication incidents that can occur during a drug shortage. The Astra Zeneca product of Suxamethonium Chloride has been in short supply and two other succinylcholine products have been made available made by other manufacturers. One of the alternative products has a slightly different concentration of active ingredient and packaging is not in English. As well the stability of the alternative products when not refrigerated is shorter. Brief recommendations to avoid medication incidents with these products are provided.

Additional Details

depolarizing neuromuscular blocker succinylcholine, suxamethonium (Succinolin®)
Medication/IV List:
neuromuscular blocking agents

Suxamethonium injection: Succinolin® Safety Considerations